GlaxoSmithKline Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (355)

Latest Posts

About This Stock More About This Stock
A Terrible Thursday Falls On Friday
Article By: Vivian Lewis
Saturday, April 21, 2018 1:14 PM EDT
More follows from a Friday behaving like a Thursday, with 6 big news breaks, including 3 corporate results plus lots of lesser news.
In this article: BLX, CEA, CZZ, DB, GSK, NVS, SLB, FANUF, IVSBF, RNSHF, TCEHY, MELI, AMZN, TEVA Also: BUD, VRGDF
Read
E Chinese And Burmese Lobbyists
Article By: Vivian Lewis
Tuesday, April 3, 2018 11:59 PM EDT
Today we have an exotic annual report to cover and lots of news. The goods range from China to India, from Mexico to Sweden, from Qatar to Israel, from Myanmar to Japan, from Switzerland to Britain, plus lots of points in between.
In this article: CEA, SQM, TCEHY, AZRE, SHPG, GSK, NVS, RHHBY, TEVA, MXCHF, CX, ALV, KUBTY, EC, SLB, VOD, FANUY, MAGS, ISL, SGF, GRR, IF, MXE, TEI
Read
4 Top-Ranked Drug/Biotech Stocks To Buy As Q1 Nears End
Article By: Zacks Investment Research
Tuesday, March 27, 2018 8:42 AM EDT
After a solid run in the first two months of the first quarter, the drug/biotech sectors struggled in March, probably on broader market pressure and a few negative updates on the pipeline and regulatory front.
In this article: GSK, LGND, HLUYY, ADVM Also: PFE, SNY, CELG
Read
GlaxoSmithKline Acquires Novartis Stake In Consumer Healthcare Venture For $13B
Article By: The Fly
Tuesday, March 27, 2018 6:44 AM EDT
GlaxoSmithKline announces that it has reached an agreement with Novartis for the buyout of Novartis' 36.5% stake in their Consumer Healthcare joint venture for $13B.
In this article: GSK, NVS
Read
Week In Review: Luye May Stage $500 Million Singapore IPO Of Healthcare Assets
Article By: ChinaBio® Today
Saturday, January 27, 2018 3:39 PM EDT
Luye Medical, the healthcare arm of Luye Life Sciences, is considering an IPO in Singapore that could raise as much as $500 million (see story). The company has assembled a portfolio of businesses, largely through M&A.
In this article: GSK, PFE, ARMO
Read

PARTNER HEADLINES

Latest Tweets for $GSK

No tweets yet!